| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 30 | 2024 | 1865 | 2.060 |
Why?
|
| Cardiac Surgical Procedures | 32 | 2025 | 1176 | 1.900 |
Why?
|
| Reoperation | 26 | 2025 | 853 | 1.560 |
Why?
|
| Postoperative Complications | 28 | 2025 | 3142 | 1.500 |
Why?
|
| Vascular Surgical Procedures | 14 | 2024 | 553 | 1.440 |
Why?
|
| Transposition of Great Vessels | 7 | 2020 | 133 | 1.430 |
Why?
|
| Heart Transplantation | 24 | 2024 | 877 | 1.410 |
Why?
|
| Heart-Assist Devices | 16 | 2023 | 1081 | 1.400 |
Why?
|
| Lung Transplantation | 17 | 2023 | 335 | 1.330 |
Why?
|
| Norwood Procedures | 7 | 2024 | 104 | 1.150 |
Why?
|
| Pulmonary Artery | 10 | 2022 | 457 | 1.080 |
Why?
|
| Scimitar Syndrome | 4 | 2021 | 52 | 1.060 |
Why?
|
| Palliative Care | 10 | 2024 | 457 | 1.040 |
Why?
|
| Aorta, Thoracic | 9 | 2024 | 540 | 1.040 |
Why?
|
| Coronary Vessel Anomalies | 6 | 2023 | 291 | 1.040 |
Why?
|
| Infant | 76 | 2025 | 13061 | 1.030 |
Why?
|
| Heart Ventricles | 15 | 2022 | 791 | 1.020 |
Why?
|
| Heart Septal Defects, Ventricular | 6 | 2018 | 133 | 1.010 |
Why?
|
| Hypoplastic Left Heart Syndrome | 8 | 2024 | 271 | 0.990 |
Why?
|
| Retrospective Studies | 83 | 2025 | 17416 | 0.930 |
Why?
|
| Treatment Outcome | 64 | 2025 | 13034 | 0.900 |
Why?
|
| Discrete Subaortic Stenosis | 2 | 2024 | 7 | 0.860 |
Why?
|
| Aortic Valve | 6 | 2024 | 483 | 0.820 |
Why?
|
| Abnormalities, Multiple | 8 | 2018 | 981 | 0.820 |
Why?
|
| Pulmonary Veins | 4 | 2021 | 174 | 0.810 |
Why?
|
| Arterial Switch Operation | 2 | 2020 | 24 | 0.790 |
Why?
|
| Time Factors | 33 | 2025 | 6448 | 0.790 |
Why?
|
| Aorta | 7 | 2023 | 550 | 0.780 |
Why?
|
| Infant, Newborn | 53 | 2024 | 8549 | 0.770 |
Why?
|
| Child, Preschool | 61 | 2025 | 14749 | 0.730 |
Why?
|
| Echocardiography | 13 | 2024 | 1129 | 0.720 |
Why?
|
| Cardiopulmonary Bypass | 12 | 2020 | 373 | 0.710 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 158 | 0.690 |
Why?
|
| Heterotaxy Syndrome | 2 | 2021 | 63 | 0.690 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2021 | 28 | 0.680 |
Why?
|
| Tracheal Stenosis | 1 | 2020 | 31 | 0.670 |
Why?
|
| Vascular Ring | 1 | 2019 | 6 | 0.630 |
Why?
|
| Humans | 140 | 2025 | 132089 | 0.610 |
Why?
|
| Child | 74 | 2025 | 25786 | 0.610 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2018 | 42 | 0.610 |
Why?
|
| Blalock-Taussig Procedure | 4 | 2022 | 49 | 0.610 |
Why?
|
| Graft Rejection | 12 | 2024 | 559 | 0.610 |
Why?
|
| Fontan Procedure | 7 | 2019 | 186 | 0.580 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 2018 | 4 | 0.580 |
Why?
|
| Male | 86 | 2025 | 64967 | 0.580 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2020 | 461 | 0.560 |
Why?
|
| Capillaries | 1 | 2018 | 71 | 0.560 |
Why?
|
| Heart Valve Prosthesis | 6 | 2020 | 331 | 0.540 |
Why?
|
| Lung Diseases | 6 | 2023 | 408 | 0.530 |
Why?
|
| Follow-Up Studies | 27 | 2024 | 5416 | 0.530 |
Why?
|
| Female | 85 | 2025 | 70695 | 0.530 |
Why?
|
| Heart Septal Defects | 3 | 2025 | 44 | 0.520 |
Why?
|
| Thoracic Surgical Procedures | 3 | 2018 | 107 | 0.520 |
Why?
|
| Heart | 4 | 2018 | 690 | 0.510 |
Why?
|
| Aortic Coarctation | 5 | 2024 | 105 | 0.470 |
Why?
|
| Tissue and Organ Procurement | 6 | 2022 | 246 | 0.460 |
Why?
|
| Graft Survival | 9 | 2017 | 474 | 0.450 |
Why?
|
| Bioprosthesis | 5 | 2020 | 121 | 0.450 |
Why?
|
| Adolescent | 51 | 2025 | 20560 | 0.430 |
Why?
|
| Length of Stay | 14 | 2024 | 1380 | 0.420 |
Why?
|
| Risk Factors | 27 | 2025 | 10946 | 0.410 |
Why?
|
| Survival Rate | 15 | 2023 | 2194 | 0.400 |
Why?
|
| Waiting Lists | 3 | 2022 | 237 | 0.380 |
Why?
|
| Cerebrovascular Circulation | 7 | 2018 | 476 | 0.380 |
Why?
|
| Pulmonary Valve | 4 | 2020 | 96 | 0.380 |
Why?
|
| Thoracic Surgery | 1 | 2014 | 166 | 0.370 |
Why?
|
| Heart-Lung Transplantation | 1 | 2012 | 24 | 0.370 |
Why?
|
| Hospital Mortality | 8 | 2024 | 1057 | 0.370 |
Why?
|
| Truncus Arteriosus, Persistent | 2 | 2021 | 18 | 0.340 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 144 | 0.330 |
Why?
|
| Heart Failure | 7 | 2023 | 2393 | 0.320 |
Why?
|
| Hydrocortisone | 4 | 2018 | 226 | 0.320 |
Why?
|
| Texas | 14 | 2020 | 3629 | 0.320 |
Why?
|
| Coronary Vessels | 4 | 2023 | 549 | 0.320 |
Why?
|
| Societies, Medical | 1 | 2014 | 779 | 0.310 |
Why?
|
| Septal Occluder Device | 1 | 2010 | 47 | 0.310 |
Why?
|
| Hypothermia, Induced | 7 | 2020 | 170 | 0.310 |
Why?
|
| Trachea | 3 | 2020 | 210 | 0.300 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 570 | 0.290 |
Why?
|
| Aortic Valve Stenosis | 4 | 2024 | 378 | 0.270 |
Why?
|
| Thoracotomy | 3 | 2019 | 110 | 0.270 |
Why?
|
| Tachycardia, Supraventricular | 2 | 2022 | 109 | 0.260 |
Why?
|
| Airway Obstruction | 2 | 2020 | 167 | 0.260 |
Why?
|
| Computed Tomography Angiography | 2 | 2018 | 215 | 0.250 |
Why?
|
| Transportation of Patients | 1 | 2006 | 54 | 0.250 |
Why?
|
| Hospitals, Pediatric | 4 | 2018 | 777 | 0.250 |
Why?
|
| Hospitals, Low-Volume | 2 | 2017 | 32 | 0.240 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2024 | 343 | 0.240 |
Why?
|
| Tissue Donors | 3 | 2022 | 504 | 0.230 |
Why?
|
| Mitral Valve Stenosis | 1 | 2025 | 39 | 0.230 |
Why?
|
| Disasters | 1 | 2006 | 106 | 0.230 |
Why?
|
| Bioprinting | 1 | 2024 | 9 | 0.220 |
Why?
|
| Spheroids, Cellular | 1 | 2024 | 63 | 0.220 |
Why?
|
| Mitral Valve | 3 | 2020 | 269 | 0.220 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 98 | 0.220 |
Why?
|
| Truncus Arteriosus | 2 | 2021 | 13 | 0.210 |
Why?
|
| Prosthesis Design | 4 | 2020 | 670 | 0.210 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2014 | 87 | 0.210 |
Why?
|
| Anastomosis, Surgical | 4 | 2018 | 167 | 0.210 |
Why?
|
| Quality of Life | 1 | 2013 | 2161 | 0.210 |
Why?
|
| Homeostasis | 2 | 2018 | 722 | 0.200 |
Why?
|
| Thoracic Wall | 1 | 2023 | 40 | 0.200 |
Why?
|
| Twins, Conjoined | 1 | 2023 | 30 | 0.200 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 56 | 0.200 |
Why?
|
| Young Adult | 17 | 2025 | 9958 | 0.200 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1103 | 0.200 |
Why?
|
| Nervous System | 2 | 2014 | 126 | 0.190 |
Why?
|
| Atrial Flutter | 1 | 2022 | 42 | 0.190 |
Why?
|
| Cell Survival | 1 | 2024 | 866 | 0.190 |
Why?
|
| Databases, Factual | 6 | 2019 | 1229 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2018 | 219 | 0.180 |
Why?
|
| Retreatment | 2 | 2020 | 93 | 0.180 |
Why?
|
| Filamins | 2 | 2021 | 27 | 0.180 |
Why?
|
| Recurrence | 4 | 2021 | 1469 | 0.180 |
Why?
|
| Vascular Diseases | 1 | 2023 | 150 | 0.180 |
Why?
|
| Tracheostomy | 2 | 2020 | 204 | 0.170 |
Why?
|
| Age Factors | 9 | 2020 | 2916 | 0.170 |
Why?
|
| Factor VIIa | 1 | 2020 | 24 | 0.170 |
Why?
|
| Tracheoesophageal Fistula | 2 | 2018 | 48 | 0.170 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 148 | 0.170 |
Why?
|
| Bronchi | 2 | 2018 | 103 | 0.170 |
Why?
|
| Cause of Death | 2 | 2017 | 510 | 0.170 |
Why?
|
| Pierre Robin Syndrome | 1 | 2020 | 29 | 0.170 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2020 | 20 | 0.170 |
Why?
|
| Aortic Arch Syndromes | 2 | 2014 | 11 | 0.160 |
Why?
|
| Postoperative Period | 5 | 2024 | 334 | 0.160 |
Why?
|
| Blood Flow Velocity | 3 | 2018 | 440 | 0.160 |
Why?
|
| Pneumonectomy | 1 | 2021 | 148 | 0.160 |
Why?
|
| Mandible | 1 | 2020 | 80 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 343 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2017 | 1132 | 0.160 |
Why?
|
| Prospective Studies | 10 | 2024 | 6572 | 0.150 |
Why?
|
| Miniaturization | 1 | 2019 | 26 | 0.150 |
Why?
|
| Coronary Circulation | 3 | 2019 | 206 | 0.150 |
Why?
|
| Pulmonary Atresia | 1 | 2019 | 49 | 0.150 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 32 | 0.150 |
Why?
|
| Brain Diseases | 2 | 2014 | 305 | 0.150 |
Why?
|
| Patient Readmission | 2 | 2021 | 425 | 0.150 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 182 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2023 | 374 | 0.150 |
Why?
|
| Bronchial Diseases | 1 | 2018 | 12 | 0.140 |
Why?
|
| Risk Assessment | 9 | 2025 | 3739 | 0.140 |
Why?
|
| Sternotomy | 1 | 2018 | 43 | 0.140 |
Why?
|
| Developmental Disabilities | 2 | 2014 | 756 | 0.140 |
Why?
|
| Hospitalization | 5 | 2018 | 1900 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 3 | 2017 | 134 | 0.140 |
Why?
|
| Esophageal Atresia | 1 | 2018 | 52 | 0.140 |
Why?
|
| Myocardial Contraction | 4 | 2017 | 256 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 75 | 0.130 |
Why?
|
| Cardiotonic Agents | 2 | 2017 | 136 | 0.130 |
Why?
|
| Device Removal | 3 | 2015 | 227 | 0.130 |
Why?
|
| Arterial Pressure | 1 | 2018 | 128 | 0.130 |
Why?
|
| Cor Triatriatum | 1 | 2017 | 10 | 0.130 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2017 | 50 | 0.130 |
Why?
|
| Atrial Septum | 1 | 2017 | 19 | 0.130 |
Why?
|
| Digestive System Abnormalities | 1 | 2017 | 40 | 0.130 |
Why?
|
| Oxygen | 4 | 2018 | 571 | 0.130 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 264 | 0.130 |
Why?
|
| Adult | 16 | 2025 | 31575 | 0.130 |
Why?
|
| Stroke | 2 | 2023 | 1085 | 0.130 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 329 | 0.130 |
Why?
|
| Scoliosis | 1 | 2018 | 143 | 0.120 |
Why?
|
| Intubation, Intratracheal | 2 | 2008 | 289 | 0.120 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 120 | 0.120 |
Why?
|
| Cardiac Output, Low | 2 | 2006 | 62 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2009 | 185 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2022 | 1009 | 0.120 |
Why?
|
| Bronchial Arteries | 1 | 2015 | 4 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 893 | 0.120 |
Why?
|
| United States | 10 | 2024 | 11667 | 0.120 |
Why?
|
| Anesthetics | 2 | 2014 | 79 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2014 | 271 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 207 | 0.120 |
Why?
|
| Registries | 3 | 2018 | 1581 | 0.110 |
Why?
|
| History, 20th Century | 2 | 2014 | 385 | 0.110 |
Why?
|
| Perfusion | 3 | 2012 | 208 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 758 | 0.110 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 41 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 245 | 0.110 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 136 | 0.110 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2014 | 42 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 1200 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2020 | 5168 | 0.100 |
Why?
|
| Vena Cava, Superior | 2 | 2004 | 59 | 0.100 |
Why?
|
| Proportional Hazards Models | 5 | 2018 | 1460 | 0.100 |
Why?
|
| Tetralogy of Fallot | 2 | 2018 | 176 | 0.100 |
Why?
|
| Survival Analysis | 6 | 2017 | 1573 | 0.100 |
Why?
|
| Williams Syndrome | 1 | 2012 | 41 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 460 | 0.090 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 1439 | 0.090 |
Why?
|
| Hemodynamics | 5 | 2018 | 852 | 0.090 |
Why?
|
| Erythropoietin | 1 | 2012 | 107 | 0.090 |
Why?
|
| Hospital Charges | 1 | 2012 | 66 | 0.090 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2011 | 19 | 0.090 |
Why?
|
| Donor Selection | 1 | 2012 | 58 | 0.090 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2012 | 223 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 161 | 0.090 |
Why?
|
| Pulmonary Subvalvular Stenosis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 175 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2023 | 277 | 0.080 |
Why?
|
| Cattle | 3 | 2021 | 569 | 0.080 |
Why?
|
| Education, Medical | 1 | 2014 | 304 | 0.080 |
Why?
|
| Heart Arrest, Induced | 4 | 2004 | 77 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2016 | 3831 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2012 | 111 | 0.080 |
Why?
|
| Child Development | 1 | 2012 | 271 | 0.080 |
Why?
|
| Comorbidity | 5 | 2017 | 1611 | 0.080 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2010 | 93 | 0.080 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2009 | 25 | 0.080 |
Why?
|
| Biomarkers | 4 | 2024 | 3407 | 0.070 |
Why?
|
| Incidence | 5 | 2018 | 3379 | 0.070 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2009 | 45 | 0.070 |
Why?
|
| Agammaglobulinemia | 1 | 2008 | 44 | 0.070 |
Why?
|
| Sternum | 1 | 2008 | 53 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 408 | 0.070 |
Why?
|
| Oxygen Consumption | 4 | 2010 | 305 | 0.070 |
Why?
|
| Cardiac Catheterization | 3 | 2019 | 664 | 0.070 |
Why?
|
| Postoperative Care | 4 | 2010 | 312 | 0.070 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 516 | 0.070 |
Why?
|
| Organophosphonates | 1 | 2007 | 21 | 0.070 |
Why?
|
| Cytosine | 1 | 2007 | 58 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 788 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2019 | 655 | 0.070 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2024 | 129 | 0.070 |
Why?
|
| Adenovirus Infections, Human | 1 | 2007 | 57 | 0.070 |
Why?
|
| Prosthesis Failure | 2 | 2020 | 164 | 0.070 |
Why?
|
| Hemoglobin SC Disease | 1 | 2007 | 9 | 0.070 |
Why?
|
| Hospital Costs | 2 | 2019 | 187 | 0.070 |
Why?
|
| Transplantation Immunology | 1 | 2007 | 45 | 0.070 |
Why?
|
| Treatment Failure | 3 | 2019 | 366 | 0.070 |
Why?
|
| Tricuspid Atresia | 1 | 2007 | 14 | 0.070 |
Why?
|
| Gestational Age | 2 | 2022 | 1224 | 0.060 |
Why?
|
| Swine | 6 | 2015 | 1182 | 0.060 |
Why?
|
| Global Health | 1 | 2012 | 644 | 0.060 |
Why?
|
| Lung | 3 | 2022 | 1559 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2017 | 1400 | 0.060 |
Why?
|
| Monitoring, Physiologic | 3 | 2018 | 377 | 0.060 |
Why?
|
| Pericardium | 1 | 2007 | 102 | 0.060 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 178 | 0.060 |
Why?
|
| Patient Transfer | 1 | 2006 | 110 | 0.060 |
Why?
|
| Pulmonary Circulation | 2 | 2021 | 117 | 0.060 |
Why?
|
| Immunocompromised Host | 1 | 2007 | 306 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2010 | 908 | 0.060 |
Why?
|
| Poloxamer | 1 | 2024 | 14 | 0.060 |
Why?
|
| Porosity | 1 | 2024 | 43 | 0.060 |
Why?
|
| Alginates | 1 | 2024 | 24 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3766 | 0.060 |
Why?
|
| Seizures | 1 | 2010 | 893 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 737 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2006 | 196 | 0.050 |
Why?
|
| Hospitals | 2 | 2021 | 438 | 0.050 |
Why?
|
| Heart Rate | 2 | 2005 | 588 | 0.050 |
Why?
|
| Allografts | 2 | 2015 | 195 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 256 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2024 | 68 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2005 | 200 | 0.050 |
Why?
|
| Brain | 5 | 2014 | 3176 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3416 | 0.050 |
Why?
|
| Cadaver | 1 | 2023 | 119 | 0.050 |
Why?
|
| Ribs | 1 | 2023 | 54 | 0.050 |
Why?
|
| Prognosis | 3 | 2017 | 5014 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 1994 | 271 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 305 | 0.050 |
Why?
|
| Animals, Newborn | 5 | 1994 | 1034 | 0.050 |
Why?
|
| Perioperative Period | 2 | 2014 | 52 | 0.050 |
Why?
|
| Linear Models | 2 | 2018 | 713 | 0.050 |
Why?
|
| Tachycardia | 1 | 2022 | 69 | 0.050 |
Why?
|
| Blood | 2 | 1994 | 102 | 0.050 |
Why?
|
| Animals | 11 | 2024 | 34798 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2017 | 435 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2007 | 391 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2007 | 822 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2017 | 466 | 0.050 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2011 | 377 | 0.040 |
Why?
|
| Morphine | 1 | 2022 | 85 | 0.040 |
Why?
|
| Bronchoscopy | 2 | 2015 | 174 | 0.040 |
Why?
|
| Methadone | 1 | 2022 | 126 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 2 | 2014 | 136 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 256 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 527 | 0.040 |
Why?
|
| Fetal Heart | 1 | 2022 | 135 | 0.040 |
Why?
|
| Replantation | 1 | 2020 | 56 | 0.040 |
Why?
|
| Micrognathism | 1 | 2020 | 67 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2022 | 180 | 0.040 |
Why?
|
| Cardioplegic Solutions | 2 | 1991 | 17 | 0.040 |
Why?
|
| Immunosuppressive Agents | 3 | 2008 | 672 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2008 | 523 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 589 | 0.040 |
Why?
|
| Osteogenesis, Distraction | 1 | 2020 | 54 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 991 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2024 | 3037 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 2018 | 652 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2169 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 116 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2018 | 236 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 154 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 1347 | 0.030 |
Why?
|
| Infant, Premature | 2 | 2017 | 843 | 0.030 |
Why?
|
| Acute Disease | 2 | 2018 | 1160 | 0.030 |
Why?
|
| Oximetry | 1 | 2018 | 178 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 512 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2019 | 485 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 471 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2018 | 260 | 0.030 |
Why?
|
| Middle Aged | 4 | 2023 | 28998 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1444 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2009 | 370 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 707 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 489 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 197 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1997 | 335 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 1997 | 824 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 504 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 1994 | 52 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1355 | 0.030 |
Why?
|
| Receptors, Complement | 1 | 1994 | 32 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1994 | 83 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 1994 | 88 | 0.030 |
Why?
|
| Critical Care | 2 | 2010 | 686 | 0.030 |
Why?
|
| Equipment Design | 2 | 2006 | 603 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2009 | 988 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 959 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 257 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2006 | 368 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2014 | 179 | 0.020 |
Why?
|
| Inhalation | 1 | 2012 | 8 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2012 | 28 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 243 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2012 | 76 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4528 | 0.020 |
Why?
|
| Plasma Substitutes | 1 | 1991 | 7 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 153 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2011 | 66 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 226 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1993 | 278 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 116 | 0.020 |
Why?
|
| Potassium Compounds | 1 | 1988 | 7 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7555 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2008 | 22 | 0.020 |
Why?
|
| Drainage | 1 | 2010 | 264 | 0.020 |
Why?
|
| Video Recording | 1 | 2010 | 204 | 0.020 |
Why?
|
| Sputum | 1 | 2009 | 116 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2008 | 126 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 286 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 216 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 79 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2008 | 219 | 0.020 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2008 | 41 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2007 | 37 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2015 | 1068 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1993 | 785 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2008 | 91 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 6228 | 0.020 |
Why?
|
| Anesthesia | 1 | 2010 | 216 | 0.020 |
Why?
|
| Sepsis | 1 | 2012 | 515 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 994 | 0.020 |
Why?
|
| Pain, Postoperative | 1 | 2010 | 272 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 761 | 0.020 |
Why?
|
| Situs Inversus | 1 | 2006 | 26 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 258 | 0.020 |
Why?
|
| Viral Load | 1 | 2008 | 404 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 1014 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 322 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2008 | 671 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 806 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2007 | 246 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 1839 | 0.010 |
Why?
|
| Hemothorax | 1 | 2005 | 20 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 2658 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 84 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2225 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2005 | 239 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1952 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 2322 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2004 | 38 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2004 | 89 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2555 | 0.010 |
Why?
|
| Aged | 2 | 2012 | 21438 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2004 | 186 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 252 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2004 | 123 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 7104 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3092 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2005 | 518 | 0.010 |
Why?
|
| Sheep | 2 | 1991 | 230 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 1303 | 0.010 |
Why?
|
| Models, Biological | 2 | 1994 | 1443 | 0.010 |
Why?
|
| Myocardium | 2 | 1991 | 908 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 1994 | 10 | 0.010 |
Why?
|
| Haplorhini | 1 | 1994 | 117 | 0.010 |
Why?
|
| Temperature | 1 | 1994 | 302 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 326 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 862 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 36 | 0.010 |
Why?
|
| Body Water | 1 | 1991 | 88 | 0.010 |
Why?
|
| Biopsy | 1 | 1994 | 1284 | 0.010 |
Why?
|
| Cyanosis | 1 | 1988 | 43 | 0.000 |
Why?
|
| Potassium | 1 | 1988 | 275 | 0.000 |
Why?
|